Renaissance Capital logo

ZTS News

Eli Lilly's Elanco may be 2018's biggest IPO

Eli Lilly's animal health division Elanco recently filed for a US offering that...read more

Renaissance Capital's 2Q 2015 Global IPO Quarterly Review

Following a seasonally calm start to the year, global IPO issuance improved in the second quarter of 2015. Quarterly proceeds increased 29% from the first quarter to $46.6 billion, but still remained down 24% from last year’s levels. IPO proceeds in the...read more

Renaissance IPO Index - Notice of March 2015 Quarterly Changes

ZTS

The Renaissance IPO Index (Ticker: IPOUSA), the underlying index for the Renaissance IPO ETF (Ticker: IPO), will implement the following constituent changes at the market’s close on Friday, March 20, 2015: Additions: Juno Therapeutics Shell...read more

Paining cats and dogs: Nexvet sets terms for $58 million IPO

Nexvet, which is developing biologics for the treatment of pain and inflammation in cats and dogs, announced terms for its IPO on Monday. The Dublin, Ireland-based company plans to raise $58 million by offering 4.0 million shares at a price range of $13 to $16....read more